Sign in

CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208623253
Phone
908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$378,930
in 4 filings, $379K under 10b5-1 plans

Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Barber Daniel −$333K President and CEO sold 11% of stake
  2. Daly Richard J +$99K Director 1 filing
  3. Korczynski Sherry −$46K Chief Commercial Officer sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2019-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise · Restricted Stock Units −14,572 58,288
2019-05-31 Kendall Keith J CEO and President Option exercise +14,572 653,186
2019-05-31 Kendall Keith J CEO and President Shares withheld for taxes −6,780 $3.72 $25K 646,406
2019-05-31 Kendall Keith J CEO and President Option exercise · Restricted Stock Units −14,572 58,288
2019-05-09 Barber Daniel SVP-Chief Operating Officer Grant or award · Non-Qualified Stock Option (right to buy) +50,000 50,000
2019-03-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise +329 1,027,971
2019-03-31 Schobel Alexander Mark Chief Innovation/Tech Officer Shares withheld for taxes −263 $6.91 $2K 1,027,708
2019-03-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise · Restricted Stock Units −329 1,649
2019-03-31 Kendall Keith J CEO and President Option exercise +329 638,877
2019-03-31 Kendall Keith J CEO and President Shares withheld for taxes −263 $6.91 $2K 638,614
2019-03-31 Kendall Keith J CEO and President Option exercise · Restricted Stock Units −329 1,649
2019-02-28 Schobel Alexander Mark SVP,Chief Innov/Tech Officer Grant or award · Non-Qualified Stock Option (right to buy) +75,000 75,000
2019-02-28 BRAENDER LORI J SVP, General Counsel Grant or award · Non-Qualified Stock Option (right to buy) +100,000 100,000
2019-02-28 Barber Daniel SVP-Chief Strategy/Dev Officer Grant or award · Non-Qualified Stock Option (right to buy) +70,000 70,000
2019-02-28 Boyd Peter E. SVP-Operations/Value Delivery Grant or award · Non-Qualified Stock Option (right to buy) +30,000 30,000
2019-02-28 Kendall Keith J CEO and President Grant or award · Non-Qualified Stock Option (right to buy) +325,000 325,000
2019-02-28 Maxwell John T. SVP-Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +95,000 95,000
2019-02-28 Wood Theresa SVP-HR and Org. Development Grant or award · Non-Qualified Stock Option (right to buy) +45,000 45,000
2019-02-28 Kendall Keith J CEO and President Option exercise +14,572 643,273
2019-02-28 Kendall Keith J CEO and President Shares withheld for taxes −4,725 $8.05 $38K 638,548

Page 20 of 24 · 462 trades